Login / Signup

Pharmacokinetic and pharmacodynamic properties of once-weekly insulin icodec in individuals with type 1 diabetes.

Ulrike HoevelmannSusanne EngbergTim HeiseNiels Rode KristensenLea NørgreenEric ZijlstraRasmus Ribel-Madsen
Published in: Diabetes, obesity & metabolism (2024)
The pharmacokinetic/pharmacodynamic properties of icodec suggest its potential to provide basal coverage in a basal-bolus insulin regimen in people with T1D.
Keyphrases
  • type diabetes
  • glycemic control
  • healthcare
  • adipose tissue